Henry Schein, Inc. (NASDAQ:HSIC) CEO Stanley M. Bergman sold 69,000 shares of Henry Schein stock in a transaction that occurred on Friday, December 7th. The shares were sold at an average price of $86.32, for a total transaction of $5,956,080.00. Following the sale, the chief executive officer now owns 240,096 shares of the company’s stock, valued at $20,725,086.72. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.
Shares of NASDAQ:HSIC traded down $2.34 during trading on Friday, hitting $85.16. 1,398,758 shares of the stock traded hands, compared to its average volume of 1,168,002. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.30 and a quick ratio of 0.70. The firm has a market cap of $13.34 billion, a price-to-earnings ratio of 23.66, a price-to-earnings-growth ratio of 2.88 and a beta of 0.89. Henry Schein, Inc. has a 52-week low of $62.56 and a 52-week high of $91.35.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, November 6th. The company reported $1.03 EPS for the quarter, topping the consensus estimate of $1.01 by $0.02. The company had revenue of $3.28 billion during the quarter, compared to analyst estimates of $3.37 billion. Henry Schein had a net margin of 3.00% and a return on equity of 20.40%. The firm’s revenue was up 3.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.87 EPS. On average, sell-side analysts anticipate that Henry Schein, Inc. will post 4.12 earnings per share for the current fiscal year.
Several analysts have commented on the stock. BidaskClub upgraded shares of Henry Schein from a “hold” rating to a “buy” rating in a research note on Wednesday, August 22nd. Cleveland Research reaffirmed a “hold” rating on shares of Henry Schein in a report on Monday, September 24th. Zacks Investment Research raised shares of Henry Schein from a “hold” rating to a “buy” rating and set a $98.00 target price for the company in a report on Friday, October 5th. Piper Jaffray Companies reaffirmed an “overweight” rating and set a $96.00 target price on shares of Henry Schein in a report on Thursday, November 29th. Finally, ValuEngine raised shares of Henry Schein from a “strong sell” rating to a “sell” rating in a report on Thursday, September 13th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. Henry Schein presently has an average rating of “Hold” and an average price target of $86.47.
COPYRIGHT VIOLATION NOTICE: “Henry Schein, Inc. (HSIC) CEO Stanley M. Bergman Sells 69,000 Shares of Stock” was originally reported by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another site, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The correct version of this piece can be viewed at https://www.com-unik.info/2018/12/08/henry-schein-inc-hsic-ceo-stanley-m-bergman-sells-69000-shares-of-stock.html.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading: When is a capital gain realized?
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.